NGS in a series of chronic inflammation DLBCL associated with breast implant described mutations in genes known to be recurrently mutated in DLBCL, such as CREBBP, GNA13, TET2, IRF4, STAT3, and SOCS1 [110]. This evidence concerns the gene GNA13 and diffuse large B-cell lymphoma.